
Azelastine Monoproduct (Astelin) for Perennial Allergic Rhinitis: FDA Approval Status
This informative article discusses the FDA approval status of azelastine monoproduct (brand name Astelin) for the treatment of perennial allergic rhinitis. It provides information about its efficacy, dosage, and potential side effects. The article is aimed at informing individuals seeking medical treatment options for allergic rhinitis.
Read more